CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide.
$50.59+0.22%
报价 2026-11-13
市值
$1.51B
EV
$2.28B
PE (TTM)
21.0x
预期 PE (FY2026)
11.1x
52 周区间距高点 -5.7%
$32.11$53.66
筛选结果
pipeline · 2026-11-13Filter✗ 高增长✗ Cheap✗ GARP
does not hit growth, cheap, or GARP pool
爆发潜力
2026-11-13未命中✗ 收入线✗ EPS 线
| 财年 | 收入倍数 | EPS | PE |
|---|---|---|---|
| FY+22027-12 | 1.0x | 4.74 → 4.75（1.0x） | 10.7 |
| FY+32028-12 | 1.1x | 4.74 → 5.24（1.1x） | 9.7 |
毛利率 57% · TTM 收入 $1370M · 基数 EPS 4.74（调整后）
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| CNMDCONMED Corporation | $1.51B | +0.2% | -0.4% | 56.4% | 21.0x | 10.8x | 11.4x | |
| NEOGNeogen Corporation | $2.45B | +0.4% | +3.6% | 47.4% | – | 31.6x | 54.7x | |
| UFPTUFP Technologies, Inc. | $2.36B | -0.3% | +9.8% | 29.3% | 33.3x | 22.8x | 41.6x | |
| ESTAEstablishment Labs Holdings Inc. | $2.11B | +3.1% | +30.6% | 69.1% | – | – | – | 高增长 |
| AZTAAzenta, Inc. | $2B | +4.1% | +6.0% | 46% | – | – | 70.1x | |
| KMTSKESTRA MEDICAL TECHNOLOGIES, LTD. | $1.71B | +0.1% | +51.5% | 56.5% | – | – | – | 高增长 |
| NVCRNovoCure Limited | $1.38B | +0.9% | +13.0% | 77% | – | – | – | |
| NTLAIntellia Therapeutics, Inc. | $1.36B | -8.1% | -23.1% | -46.5% | – | – | – | |
| AHCOAdaptHealth Corp. | $1.05B | -2.7% | -10.0% | 15.4% | – | 37.6x | 13.0x | |
| 同行中位数 | – | – | +7.9% | 46.7% | 33.3x | 31.6x | 48.1x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
| Metric | 2026-09-30 Q3 2026 | 2026-06-30 Q2 2026 | 2026-03-31 Q1 2026 | 2025-12-31 Q4 2025 | 2025-09-30 Q3 2025 | 2025-06-30 Q2 2025 | 2025-03-31 Q1 2025 | 2024-12-31 Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $335.6M | $343.5M | $317M | $373.5M | $338.6M | $343M | $319.4M | $345.9M |
| Gross Margin | 56.4% | 57.5% | 57.9% | 57.1% | 46.7% | 52.6% | 52.6% | 57.3% |
| Operating Margin | 11.1% | 10.6% | 8% | 17.9% | 5.7% | 12.2% | 3.6% | 15.2% |
| Net Income | $19.8M | $23.1M | $13.8M | $16.7M | $2.9M | $21.4M | $6M | $33.8M |
| Diluted EPS | 0.66 | 0.77 | 0.45 | 0.54 | 0.09 | 0.69 | 0.19 | 1.08 |
| Operating Cash Flow | $49.4M | $37.1M | $13.5M | $46.3M | $53.7M | $29.1M | $41.5M | $43.3M |